EC Number |
Substrates |
Organism |
Products |
Reversibility |
---|
1.1.1.32 | (R)-3-hydroxy-3-methyl-5-oxovaleric acid + NADH |
- |
Sus scrofa |
(R)-3-hydroxy-3-methyl-5-hydroxyvaleric acid + NAD+ |
- |
? |
1.1.1.32 | (R)-3-hydroxy-3-methyl-5-oxovaleric acid + NADH |
- |
Sus scrofa |
(R)-3-hydroxy-3-methyl-5-hydroxyvaleric acid + NAD+ |
- |
ir |
1.1.1.32 | (R)-3-hydroxy-3-methyl-5-oxovaleric acid + NADPH |
- |
Sus scrofa |
(R)-3-hydroxy-3-methyl-5-hydroxyvaleric acid + NADP+ |
- |
? |
1.1.1.32 | (R)-3-hydroxy-3-methyl-5-oxovaleric acid + NADPH |
- |
Sus scrofa |
(R)-3-hydroxy-3-methyl-5-hydroxyvaleric acid + NADP+ |
- |
ir |
1.1.1.32 | mevaldate + NADH + H+ |
- |
Sus scrofa |
(R)-mevalonate + NAD+ |
- |
r |
1.1.1.32 | (S)-3-hydroxy-3-methyl-5-oxovaleric acid + NADH |
- |
Sus scrofa |
(S)-3-hydroxy-3-methyl-5-hydroxyvaleric acid + NAD+ |
- |
? |
1.1.1.32 | (S)-3-hydroxy-3-methyl-5-oxovaleric acid + NADH |
- |
Sus scrofa |
(S)-3-hydroxy-3-methyl-5-hydroxyvaleric acid + NAD+ |
- |
ir |